Login / Signup

Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya.

James H KimothoAbdiaziz A GosarRonald InyangalaPaulyne WairimuFred SiyoiMatoke-Muhia DamarisCecilia WanjalaJeremiah ZablonMoses OrinaLucy MuitaJacqueline ThigaLameck NyabutiEunice WainainaJoseph MwangiAlice MumbiSamuel OmariAnn WanjiruSamson Muuo NzouMissiani Ochwoto
Published in: African journal of laboratory medicine (2021)
Serological-based PoCTs available in Kenya can only detect COVID-19 in up to 60% of the infected population.
Keyphrases
  • coronavirus disease
  • sars cov
  • high throughput
  • respiratory syndrome coronavirus
  • clinical evaluation